lobbying_activities: 1840221

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1840221	2315aa67-237d-4d2b-b1c4-cf6c539d0881	Q2	WILLIAMS AND JENSEN, PLLC	41454	TAKEDA PHARMACEUTICALS AMERICA, INC.	2016	second_quarter	MMM	Medicare prescription drug benefit; Rebates for Medicare Part D; Independent Payment Advisory Board (IPAB); Part D coverage for obesity drugs; H.R. 2404/S. 1509, the Treat and Reduce Obesity Act of 2015; Medicare coverage for Alzheimer's diagnostics; payment policies for Medicare Part B prescription drugs.	HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE	50000		0	0	2016-07-12T14:14:28.010000-04:00